Terns Pharmaceuticals (TERN) has had the highest return between October 17, 2025 and December 17, 2025 by a mid-cap US stock, returning 408.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Terns Pharmaceuticals (TERN) | 10/17/2025 - 12/17/2025 | 408.53% |
Olema Pharmaceuticals (OLMA) | 10/17/2025 - 12/17/2025 | 268.21% |
PACS (PACS) | 10/17/2025 - 12/17/2025 | 176.7% |
Cogent Biosciences (COGT) | 10/17/2025 - 12/17/2025 | 147.77% |
Nuvation Bio (NUVB) | 10/17/2025 - 12/17/2025 | 143.94% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 10/17/2025 - 12/17/2025 | 128.05% |
Cidara Therapeutics (CDTX) | 10/17/2025 - 12/17/2025 | 121.69% |
Wave Life Sciences (WVE) | 10/17/2025 - 12/17/2025 | 108.51% |
Celcuity LLC (CELC) | 10/17/2025 - 12/17/2025 | 95.05% |
American Eagle Outfitters (AEO) | 10/17/2025 - 12/17/2025 | 83.99% |
Victoria's Secret (VSCO) | 10/17/2025 - 12/17/2025 | 78.93% |
BBVA Banco Frances SA ADR (BBAR) | 10/17/2025 - 12/17/2025 | 77.01% |
Arrowhead Pharmaceuticals (ARWR) | 10/17/2025 - 12/17/2025 | 69.27% |
Central Puerto (CEPU) | 10/17/2025 - 12/17/2025 | 69.16% |
Lemonade (LMND) | 10/17/2025 - 12/17/2025 | 68.59% |
Abercrombie & Fitch (ANF) | 10/17/2025 - 12/17/2025 | 68.48% |
Banco Macro SA B ADR (BMA) | 10/17/2025 - 12/17/2025 | 65.2% |
Haemonetics (HAE) | 10/17/2025 - 12/17/2025 | 63.13% |
Belite Bio Inc ADR (BLTE) | 10/17/2025 - 12/17/2025 | 62.24% |
Establishment Labs (ESTA) | 10/17/2025 - 12/17/2025 | 60.36% |
Vera Therapeutics (VERA) | 10/17/2025 - 12/17/2025 | 59.72% |
Vicor (VICR) | 10/17/2025 - 12/17/2025 | 57.46% |
Liquidia Technologies (LQDA) | 10/17/2025 - 12/17/2025 | 56.09% |
Liberty Oilfield Services (LBRT) | 10/17/2025 - 12/17/2025 | 55.78% |
Immunovant (IMVT) | 10/17/2025 - 12/17/2025 | 53.46% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
